ATHE
Alterity Therapeutics Limited American Depositary Shares
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
Alterity Therapeutics (ATHE) Stock: Buy, Sell, or Hold?
$1.96
-0.14 (-6.44%)
βΌ
5d:
-19.34%
30d:
-27.94%
90d:
-57.11%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (47%)
Quality Score
41/100
Position
OVERSOLD
30-Day Fair Range
$2.09 β $2.86
Position: OVERSOLD
Forward P/E & Valuation
-2.2x
Next 12M consensus est.
Wall Street Target
$13.25
+576.0% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$1.70 / $3.29
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
βΈοΈ WAIT FOR STABILIZATION: ATHE is down 19.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ATHE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ATHE is currently trading at $1.96, which is considered oversold relative to its 30-day fair value range of $2.09 to $2.86.
Technical Outlook: Technically, ATHE is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $3.29. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: ATHE scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+576.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATHE is in a strong downtrend. Immediate support is located at $1.70, while resistance sits at $3.29. Short-term momentum is weak, with the stock down 6.4% recently.
Market Sentiment: ATHE scores 33/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $13.25 (+576.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.09 -
$2.86
Company Quality Score
41/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
Trading Range & Key Levels
30-Day Trading Range
$2.09 -
$2.86
Current vs Trading Range
OVERSOLD
Support Level
$1.70
Resistance Level
$3.29
Current Trend
Strong Downtrend
Technical data as of
Nov 13, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (33/100)
- BEARISH: Downward momentum (-6.4%)
- BULLISH: Trading 576.0% below Wall St target ($13.25)
- WARNING: Composite score 41/100 in the bottom quintile β this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.20
Wall Street Target
$13.25
(+576.0%)
Revenue Growth (YoY)
-79.0%
Share ATHE Analysis
Share this live ATHE analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ATHE)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Jan 21, 2022
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on ATHE are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 14, 2026 6:43 AM ET
Data refreshes hourly during market hours. Next update: 7:43 AM
Data refreshes hourly during market hours. Next update: 7:43 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATHE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CYTK
Cytokinetics Inc |
STRONG BUY
22 analysts |
$107 | 69 BUY |
|
INSM
Insmed Inc |
STRONG BUY
24 analysts |
$194 | 41 HOLD |
|
MDGL
Madrigal Pharmaceuticals⦠|
STRONG BUY
19 analysts |
$689 | 48 HOLD |
|
IMNM
ImmunomeΒ Inc |
STRONG BUY
17 analysts |
$35 | 47 HOLD |
|
CRNX
Crinetics Pharmaceutical⦠|
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ATHE Research Pages